1. Home
  2. CTMX vs RFM Comparison

CTMX vs RFM Comparison

Compare CTMX & RFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • RFM
  • Stock Information
  • Founded
  • CTMX 2008
  • RFM 2020
  • Country
  • CTMX United States
  • RFM United States
  • Employees
  • CTMX N/A
  • RFM N/A
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • RFM Finance/Investors Services
  • Sector
  • CTMX Health Care
  • RFM Finance
  • Exchange
  • CTMX Nasdaq
  • RFM Nasdaq
  • Market Cap
  • CTMX 85.3M
  • RFM 92.3M
  • IPO Year
  • CTMX 2015
  • RFM N/A
  • Fundamental
  • Price
  • CTMX $0.84
  • RFM $15.61
  • Analyst Decision
  • CTMX Buy
  • RFM
  • Analyst Count
  • CTMX 6
  • RFM 0
  • Target Price
  • CTMX $5.77
  • RFM N/A
  • AVG Volume (30 Days)
  • CTMX 847.0K
  • RFM 20.7K
  • Earning Date
  • CTMX 03-10-2025
  • RFM 01-01-0001
  • Dividend Yield
  • CTMX N/A
  • RFM 9.74%
  • EPS Growth
  • CTMX N/A
  • RFM N/A
  • EPS
  • CTMX 0.16
  • RFM N/A
  • Revenue
  • CTMX $126,617,000.00
  • RFM N/A
  • Revenue This Year
  • CTMX $22.55
  • RFM N/A
  • Revenue Next Year
  • CTMX N/A
  • RFM N/A
  • P/E Ratio
  • CTMX $5.20
  • RFM N/A
  • Revenue Growth
  • CTMX 33.66
  • RFM N/A
  • 52 Week Low
  • CTMX $0.79
  • RFM $12.89
  • 52 Week High
  • CTMX $5.85
  • RFM $16.41
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 45.15
  • RFM 65.66
  • Support Level
  • CTMX $0.82
  • RFM $15.24
  • Resistance Level
  • CTMX $0.98
  • RFM $15.60
  • Average True Range (ATR)
  • CTMX 0.06
  • RFM 0.07
  • MACD
  • CTMX 0.01
  • RFM 0.05
  • Stochastic Oscillator
  • CTMX 33.58
  • RFM 99.98

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About RFM RiverNorth Flexible Municipal Income Fund Inc.

RiverNorth Flexible Municipal Income Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.

Share on Social Networks: